Prostatis Group’s iShares US Financials ETF IYF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.08M Sell
8,463
-3,028
-26% -$376K 0.25% 74
2026
Q1
$1.35M Buy
11,491
+9,137
+388% +$1.13M 0.35% 64
2025
Q4
$303K Sell
2,354
-183
-7% -$22.9K 0.07% 136
2025
Q3
$321K Sell
2,537
-36,420
-93% -$4.5M 0.08% 122
2025
Q2
$4.71M Buy
38,957
+10,512
+37% +$1.18M 1.35% 20
2025
Q1
$3.21M Sell
28,445
-43,038
-60% -$4.93M 1.01% 27
2024
Q4
$7.9M Buy
+71,483
New +$7.96M 2.3% 9
2023
Q3
Sell
-81,847
Closed -$81.8K 173
2023
Q2
$81.8K Buy
+81,847
New +$5.9M 0.04% 147
2023
Q1
Sell
-2,652
Closed -$200K 106
2022
Q4
$200K Buy
+2,652
New +$199K 0.12% 95

Other funds holding IYF

Prostatis Group's IYF Position: Q2 2026 in Review

Prostatis Group reduced its iShares US Financials ETF (IYF) stake by 26% in Q2 2026, selling an estimated $376K and leaving 8,463 shares worth $1.08M. The position accounts for 0.25% of the portfolio, ranked #74.

Prostatis Group first reported a position in IYF in Q4 2022 and has held it in 9 quarters since. The position peaked at $7.9M in Q4 2024. 460 funds tracked by Wall St. Rank hold IYF as of Q2 2026.

  • Prostatis Group held 8,463 shares of iShares US Financials ETF worth $1.08M as of Q2 2026.
  • Prostatis Group sold 3,028 iShares US Financials ETF shares in Q2 2026, an estimated $376K.
  • iShares US Financials ETF made up 0.25% of Prostatis Group's portfolio in Q2 2026, its #74 holding.
  • Prostatis Group first reported a position in iShares US Financials ETF in Q4 2022 and has held it in 9 quarters since.
  • Prostatis Group's iShares US Financials ETF position peaked at $7.9M in Q4 2024.
  • 460 funds tracked by Wall St. Rank held iShares US Financials ETF as of Q2 2026.

Based on Prostatis Group's 13F filing for Q2 2026, filed 14 Aug 2026.